ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly noncontrolling interests ($M) [through Q3 2025] ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2024
79.5
Period ended Dec 31, 2024
Change on a year earlier
-13.4%
91.8 in FY2023
History
17 years
Since FY2008
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Noncontrolling interests ($M) [through Q3 2025] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 79.5 | -13.4% | Form 10-K (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | 91.8 | -26.9% | Form 10-K (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 126 | -28.5% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 176 | -4.4% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 184 | +99.1% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 92.2 | -91.5% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 1,080 | +1,327.2% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 75.7 | +4.0% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 72.8 | +283.2% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 19 | +27.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 14.9 | +60.2% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 9.30 | +6.9% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 8.70 | -242.6% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | -6.10 | -18.7% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | -7.50 | -568.7% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 1.60 | -33.3% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 2.40 | – | Form 10-Q (filed 2009-07-31) ↗ |
Cite this data
StockData. (2026). Eli Lilly Noncontrolling interests ($M) [through Q3 2025] ($M), annual FY2008–FY2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_nci
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.